Microplastics and Misinformation: What Science Really Says
November 12, 2025
Brand Name :
N/A
Synonyms :
Chai-hu, Thorowax, Bupleuri radix, Hare’s ear root
Class :
Gastrointestinal,Herbal Endocrine
Dosage Forms & Strengths Â
Extract Â
100 mg Â
500 mg Â
Off-label:
Indicated for hepatitis
A recent study highlighted synergistic effects between bupleurum and scutellaria (skullcap), demonstrating their ability to effectively target and treat liver disorders by enhancing penetration into the liver
Standard doses range from 100 to 500 mg once daily to twice daily
However, these are commonly blended at 50 to 200 mg in multiherb formulations taken once daily to twice daily
PEDIATRIC DOSINGÂ Â
Dosage Forms & StrengthsÂ
Data not availableÂ
GERIATRIC DOSINGÂ Â
Refer to adult dosing
induction of these enzymes is shown by bupleurum at high doses
induction of these enzymes is shown by bupleurum at high doses
induction of these enzymes is shown by bupleurum at high doses
induction of these enzymes is shown by bupleurum at high doses
induction of these enzymes is shown by bupleurum at high doses
Actions and SpectrumÂ
Sapogenin A compound found in bupleurum has analgesic properties. The activation of the L-arginine-NO-cGMP-KATP channel and the interaction of the opioid, PPAR, and cannabinoid receptors are what give bupleurum its antinociceptive properties. Polysaccharide bupleurans and saikosaponins both improve the rate of ulcer healing and lessen the consequences of stomach ulcers. It has vasorelaxant properties as well.Â
Frequency not defined Â
Liver damage Â
Increased flatulence Â
An increase in bowel movements Â
Adult respiratory distress syndrome Â
Sedation Â
Drowsiness Â
Blackbox warningÂ
Avoid driving vehicles and operating the machines Â
Contraindication/Caution:Â
Contraindication:Â
PregnancyÂ
LactationÂ
SLE (systemic lupus erythematosus)Â
Rheumatoid arthritisÂ
Caution:Â
Bleeding disordersÂ
Diabetes Â
CancerÂ
Hepatic impairmentÂ
Pregnancy consideration:Â Â
Safety and efficacy study about the use of bupleurum in pregnancy is not established Â
Lactation:Â Â
Safety and efficacy studies about the use of bupleurum in breastfeeding mothers have not been established.Â
Pregnancy categories:Â Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the foetus `in either the first or second trimester.Â
<b>Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category Â
PharmacologyÂ
The extracts might be a useful source of pharmacological compounds with potential for anorectic and anti-addictive effects. A saikosaponin-enriched B. falcatum extract has been shown to reduce rats’ self-administration of alcohol and chocolate.Â
PharmacodynamicsÂ
Limited information availableÂ
PharmacokineticsÂ
Not much data present on the ADMEÂ
AdministrationÂ
It is administered orallyÂ
Patient information leaflet Â
Generic Name: bupleurum Â
Why do we use bupleurum? Â
A natural supplement called bupleurum is used. It offers a wide range of therapeutic benefits. It has protection from liver, fever reducing property, pain reduction and anti-inflammatory properties. It is also recommended for the treatment of diabetes and ulcer repair.Â